These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 473840)

  • 1. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
    Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
    Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
    Illig L; Paul E
    Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of malignant melanoma with dinitrochlorobenzene ointment].
    Loth H; Ehring F
    Hautarzt; 1978 Mar; 29(3):141-6. PubMed ID: 640834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNCB immunotherapy for removal of melanoma skin metastases].
    Wätzig V
    Dermatol Monatsschr; 1977 Oct; 163(10):848-50. PubMed ID: 923876
    [No Abstract]   [Full Text] [Related]  

  • 5. Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).
    Illig L; Paul E; Bödeker RH
    Anticancer Res; 1984; 4(4-5):293-8. PubMed ID: 6486734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
    Lukács L; István M
    Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dinitrochlorobenzene. Therapeutic use].
    Heid E; Grosshans E; Laplanche G; Caussade P
    Ann Dermatol Venereol; 1984; 111(9):841-9. PubMed ID: 6393839
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation of malignant melanoma by contact sensitizing agents.
    Trowbridge RM; Mitkov MV; Pittelkow MR; Agrawal DK
    Expert Rev Clin Immunol; 2014 Jan; 10(1):63-76. PubMed ID: 24308833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.
    Stricker RB; Goldberg B; Epstein WL
    Immunol Lett; 1997 Dec; 59(3):145-50. PubMed ID: 9419021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS.
    Stricker RB; Elswood BF
    Immunol Lett; 1991 Aug; 29(3):191-6. PubMed ID: 1769706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant DNCB immunotherapy in malignant melanoma].
    Weidner F; Djawari D
    Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.